RLN2 (RXFP1 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 from Creative Biolabs

The vector of RLN2 chimeric antigen receptor (CAR) is a ligand-based CAR constructed for the engineering of T cells to target human RXFP1. The T cells are genetically modified through transduction with a lentiviral vector expressing expressing protein of PD-1 RLN2 linked to CD28 and CD3ζ signaling domains